Drug Safety Alerts

Attention (ALERT)!

Tablet VEGA 100 Suspected to contain Allopathic Ingredient “Sildenafil Citrate”.

Tablet: VEGA 100

Description: Blue Coloured Tetragonal Tablets, Engraved 100 On One Side.

Batch No. SC-121

Exp. Date: December 2020

Manufactured by: Combitic Global D-2 Industrial Area India.

Background: Provincial Drug Inspector collected the sample from Boson Town, Multan and sent it to the Punjab Drug Testing Laboratory (DTL) for testing and analysis.

Problem: DTL found Allopathic Ingredient “Sildenafil Citrate” in this preparation. Sildenafil Citrate is a Vasodilator and may have severe adverse effect in specific population. Therefore, DTL has declared it SUB-STANDARD!

Recommendation: This product does not meet appropriate quality standards and specifications and may therefore, be ineffective and potentially harmful to patients. All concerned are intimated to keep caution in procurement, dispensation, promotion and use of this pharmaceutical product.

Note. Healthcare professionals and consumers are encouraged to report adverse events or side effects related to the use of any pharmaceutical product to Provincial Drugs Control Unit Punjab through mentioned URL: mss.punjab.gov.pk/reporttgrp


Drug Safety Alerts,

Provincial Drug Control Unit,

Primary & Secondary Healthcare Department,

Govt. of the Punjab